Wiktoria M Suchorska

8PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNanotoxicology, health and safetyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models.

|Dec 30, 2025
Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models.

Piotr Stasiak, Justyna Sopel, Julia Maria Lipowicz

|Jun 26, 2025
Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs.

Piotr Stasiak, Justyna Sopel, Artur Płóciennik

|Feb 13, 2025
The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models.

Piotr Stasiak, Justyna Sopel, Julia Maria Lipowicz

|Aug 29, 2024
Genes Co-Expressed with ESR2 Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis.

Julia Maria Lipowicz, Agnieszka Malińska, Michał Nowicki

|Jun 27, 2024
Understanding Hypoxia-Driven Tumorigenesis: The Interplay of HIF1A, DNA Methylation, and Prolyl Hydroxylases in Head and Neck Squamous Cell Carcinoma.

Julia Ostapowicz, Kamila Ostrowska, Agnieszka A Rawłuszko-Wieczorek

Pageof 2

Frequent Collaborators

4 joint publications

Piotr Stasiak

4 joint publications

Jan Korbecki

4 joint publications

Radosław Januchowski

3 joint publications

Wojciech Golusiński